Home › Companies › TG THERAPEUTICS INC. › 2023-2024
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and TG THERAPEUTICS INC.’s Form 8-K, filed June 17, 2024 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 14, 2024: 10 items on TG THERAPEUTICS INC.’s Form 8-K, filed June 17, 2024: 7 passed (calculated) · 3 plurality election.
Significant dissent: 6 directors (56.3%, 54.0%, 53.9%, 31.6%, 24.8%, 24.1% against); 1 say-on-pay vote (57.7% support).
Notable dissent: 1 other board item (33.0% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore TG THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are TG THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 17, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Michael S. Weiss | 57,264,472 | -- | -- | 18,849,954 | 34,960,603 | 75% | Passed (calculated) | — |
| Elect Director: Laurence N. Charney | 57,758,626 | -- | -- | 18,355,800 | 34,960,603 | 76% | Passed (calculated) | — |
| Elect Director: Yann Echelard | 35,052,596 | -- | -- | 41,061,830 | 34,960,603 | 46.1% | Plurality election | — |
| Elect Director: Kenneth Hoberman | 52,058,723 | -- | -- | 24,055,703 | 34,960,603 | 68% | Passed (calculated) | — |
| Elect Director: Daniel Hume | 35,036,823 | -- | -- | 41,077,603 | 34,960,603 | 46.0% | Plurality election | — |
| Elect Director: Sagar Lonial, MD | 33,299,870 | -- | -- | 42,814,556 | 34,960,603 | 44% | Plurality election | — |
| 2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024 | 110,028,319 | 657,578 | 389,132 | -- | -- | 99.4% | Passed (calculated) | — |
| 3. Advisory vote to approve the compensation of the Company's named executive officers | 42,346,581 | 31,019,084 | 2,748,761 | -- | 34,960,603 | 58% | Passed (calculated) | — |
| 4. The vote to approve the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 175,000,000 to 190,000,000 | 73,780,225 | 36,348,764 | 946,040 | -- | -- | 67% | Passed (calculated) | — |
| 5. The vote to approve the amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit | 66,744,142 | 8,625,685 | 744,599 | -- | 34,960,603 | 89% | Passed (calculated) | — |
Source: TG THERAPEUTICS INC., Form 8-K, filed with the SEC on June 17, 2024 — read the filing on EDGAR.
See voting trends for Health Care companies, 2023-2024: shareholder support by sector and by company size.
242 asset managers disclosed a vote on at least one TG THERAPEUTICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
46.0% Plurality election · of votes cast
Prior year: 40.5% for (June 14, 2023 meeting) ▲ 5.6 pts
Description as filed by funds: Election of Directors: Daniel Hume
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Daniel Hume”): 35,036,823 for, 41,077,603 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 46.0% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 4,638,977 for, 20,108,064 withheld, 126,293 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,066,304 | 0 | 0 | 13,143,664 | Mixed |
| State Street | 1,768 | 0 | 0 | 1,621,193 | Withhold |
| TIAA | 0 | 0 | 0 | 1,217,287 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 1,148,610 | Withhold |
| Fidelity | 750,986 | 0 | 0 | 204,726 | Mixed |
| BlackRock | 0 | 0 | 0 | 877,944 | Withhold |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 374,322 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 177,050 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 175,509 | Withhold |
| First Trust | 0 | 0 | 0 | 157,249 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 145,974 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 127,185 | Withhold |
| SEI | 0 | 0 | 0 | 110,717 | Withhold |
| ProShares | 0 | 0 | 0 | 101,760 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 72,333 | Withhold |
| Global X | 0 | 0 | 0 | 63,047 | Withhold |
| Guggenheim | 0 | 0 | 0 | 60,516 | Withhold |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 0 | 0 | 0 | 47,089 | Withhold |
| JPMorgan | 0 | 0 | 46,996 | 0 | Abstain |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 30,412 | Withhold |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 27,853 | Withhold |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
68% Majority: yes · of votes cast
Prior year: 58.6% for (June 14, 2023 meeting) ▲ 9.8 pts
Description as filed by funds: Election of Directors: Kenneth Hoberman
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Kenneth Hoberman”): 52,058,723 for, 24,055,703 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 68% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 19,671,625 for, 5,075,416 withheld, 126,293 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,620,598 | 0 | 0 | 2,363 | For |
| TIAA | 0 | 0 | 0 | 1,217,287 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 1,148,610 | Withhold |
| Fidelity | 879,790 | 0 | 0 | 75,922 | Mixed |
| BlackRock | 0 | 0 | 0 | 877,944 | Withhold |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 374,322 | Withhold |
| Lincoln Financial | 116,000 | 0 | 0 | 61,050 | Mixed |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 175,509 | Withhold |
| First Trust | 0 | 0 | 0 | 157,249 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 145,974 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 127,185 | Withhold |
| SEI | 0 | 0 | 0 | 110,717 | Withhold |
| ProShares | 0 | 0 | 0 | 101,760 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 72,333 | Withhold |
| Global X | 0 | 0 | 0 | 63,047 | Withhold |
| Guggenheim | 0 | 0 | 0 | 60,516 | Withhold |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 0 | 0 | 0 | 47,089 | Withhold |
| JPMorgan | 0 | 0 | 46,996 | 0 | Abstain |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 30,412 | Withhold |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 27,853 | Withhold |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Prior year: 66.1% for (June 14, 2023 meeting) ▲ 9.8 pts
Description as filed by funds: Election of Directors: Laurence Charney
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Laurence N. Charney”): 57,758,626 for, 18,355,800 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 21,075,399 for, 3,697,457 withheld, 100,478 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,620,598 | 0 | 0 | 2,363 | For |
| TIAA | 0 | 0 | 0 | 1,217,287 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 1,148,610 | Withhold |
| Fidelity | 953,572 | 0 | 0 | 2,140 | For |
| BlackRock | 877,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 213,402 | 0 | 0 | 160,920 | Mixed |
| Lincoln Financial | 116,000 | 0 | 0 | 61,050 | Mixed |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 175,509 | Withhold |
| First Trust | 0 | 0 | 0 | 157,249 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 145,974 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 127,185 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 110,717 | Withhold |
| ProShares | 0 | 0 | 0 | 101,760 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 72,333 | Withhold |
| Global X | 0 | 0 | 0 | 63,047 | Withhold |
| Guggenheim | 0 | 0 | 0 | 60,516 | Withhold |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 47,089 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 0 | 46,996 | 0 | Abstain |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 30,412 | 0 | 0 | 0 | For |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 27,853 | Withhold |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
75% Majority: yes · of votes cast
Prior year: 75.8% for (June 14, 2023 meeting) ▼ 0.6 pts
Description as filed by funds: Election of Directors: Michael S. Weiss
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Michael S. Weiss”): 57,264,472 for, 18,849,954 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 75% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 20,683,032 for, 4,139,496 withheld, 50,806 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,768 | 0 | 0 | 1,621,193 | Withhold |
| TIAA | 0 | 0 | 0 | 1,217,287 | Withhold |
| Charles Schwab | 1,148,610 | 0 | 0 | 0 | For |
| Fidelity | 953,572 | 0 | 0 | 2,140 | For |
| BlackRock | 877,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 213,402 | 0 | 0 | 160,920 | Mixed |
| Lincoln Financial | 0 | 0 | 0 | 177,050 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 175,509 | Withhold |
| First Trust | 0 | 0 | 0 | 157,249 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 145,974 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 127,185 | 0 | 0 | 0 | For |
| SEI | 110,717 | 0 | 0 | 0 | For |
| ProShares | 0 | 0 | 0 | 101,760 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 72,333 | Withhold |
| Global X | 63,047 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 0 | 60,516 | Withhold |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 47,089 | 0 | 0 | 0 | For |
| JPMorgan | 46,996 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 45,536 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 30,412 | 0 | 0 | 0 | For |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 27,853 | Withhold |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
44% Plurality election · of votes cast
Prior year: 39.5% for (June 14, 2023 meeting) ▲ 4.2 pts
Description as filed by funds: Election of Directors: Sagar Lonial, MD
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Sagar Lonial, MD”): 33,299,870 for, 42,814,556 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 44% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 3,971,258 for, 20,775,783 withheld, 126,293 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,066,304 | 0 | 0 | 13,143,664 | Mixed |
| State Street | 1,768 | 0 | 0 | 1,621,193 | Withhold |
| TIAA | 0 | 0 | 0 | 1,217,287 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 1,148,610 | Withhold |
| Fidelity | 128,804 | 0 | 0 | 826,908 | Mixed |
| BlackRock | 0 | 0 | 0 | 877,944 | Withhold |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 374,322 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 177,050 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 175,509 | Withhold |
| First Trust | 0 | 0 | 0 | 157,249 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 145,974 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 127,185 | Withhold |
| SEI | 0 | 0 | 0 | 110,717 | Withhold |
| ProShares | 0 | 0 | 0 | 101,760 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 72,333 | Withhold |
| Global X | 0 | 0 | 0 | 63,047 | Withhold |
| Guggenheim | 0 | 0 | 0 | 60,516 | Withhold |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 0 | 0 | 0 | 47,089 | Withhold |
| JPMorgan | 0 | 0 | 46,996 | 0 | Abstain |
| Voya | 0 | 0 | 0 | 45,536 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 30,412 | Withhold |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 27,853 | Withhold |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
46.1% Plurality election · of votes cast
Prior year: 40.4% for (June 14, 2023 meeting) ▲ 5.6 pts
Description as filed by funds: Election of Directors: Yann Echelard
TG THERAPEUTICS INC.’s own tally for this item (“Elect Director: Yann Echelard”): 35,052,596 for, 41,061,830 withheld, per its Form 8-K filed June 17, 2024 (Item 5.07). This is a for/withhold election, which is decided by plurality: a nominee does not need a majority of the votes cast to be elected, so no passed or failed outcome is stated here.
Outcome: Plurality election — The company’s filing reports the vote counts but does not state the outcome; this is an election decided by plurality, so a nominee does not need a majority of the votes cast and no passed or failed outcome is calculated.
Support: 46.1% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 56 asset managers below reported 4,638,484 for, 20,108,557 withheld, 126,293 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 3,066,304 | 0 | 0 | 13,143,664 | Mixed |
| State Street | 1,768 | 0 | 0 | 1,621,193 | Withhold |
| TIAA | 0 | 0 | 0 | 1,217,287 | Withhold |
| Charles Schwab | 0 | 0 | 0 | 1,148,610 | Withhold |
| Fidelity | 750,986 | 0 | 0 | 204,726 | Mixed |
| BlackRock | 0 | 0 | 0 | 877,944 | Withhold |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 0 | 374,322 | Withhold |
| Lincoln Financial | 0 | 0 | 0 | 177,050 | Withhold |
| Direxion Shares ETF Trust | 0 | 0 | 0 | 175,509 | Withhold |
| First Trust | 0 | 0 | 0 | 157,249 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 145,974 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 127,185 | Withhold |
| SEI | 0 | 0 | 0 | 110,717 | Withhold |
| ProShares | 0 | 0 | 0 | 101,760 | Withhold |
| AIG/SunAmerica | 0 | 0 | 0 | 72,333 | Withhold |
| Global X | 0 | 0 | 0 | 63,047 | Withhold |
| Guggenheim | 0 | 0 | 0 | 60,516 | Withhold |
| John Hancock | 0 | 0 | 50,793 | 0 | Abstain |
| Pacific Life | 0 | 0 | 0 | 47,089 | Withhold |
| JPMorgan | 0 | 0 | 46,996 | 0 | Abstain |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 30,412 | Withhold |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 0 | 0 | 27,853 | Withhold |
Showing the 25 largest of 56 asset managers. All 56 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
67% Majority: yes · of votes cast
Description as filed by funds: TO APPROVE AN AMENDMENT TO OUR CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON STOCK FROM 175,000,000 TO 190,000,000.
TG THERAPEUTICS INC.’s own tally for this item (“4. The vote to approve the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of Common Stock from 175,000,000 to 190,000,000”): 73,780,225 for, 36,348,764 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 67% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 58 asset managers below reported 22,413,799 for, 2,463,299 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,620,598 | 2,363 | 0 | 0 | For |
| TIAA | 1,217,287 | 0 | 0 | 0 | For |
| Charles Schwab | 1,148,610 | 0 | 0 | 0 | For |
| Fidelity | 879,790 | 75,922 | 0 | 0 | Mixed |
| BlackRock | 0 | 877,944 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 0 | 374,322 | 0 | 0 | Against |
| Lincoln Financial | 116,000 | 61,050 | 0 | 0 | Mixed |
| Direxion Shares ETF Trust | 0 | 175,509 | 0 | 0 | Against |
| First Trust | 0 | 157,249 | 0 | 0 | Against |
| Goldman Sachs | 145,974 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 127,185 | 0 | 0 | Against |
| SEI | 110,717 | 0 | 0 | 0 | For |
| ProShares | 0 | 101,760 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 72,333 | 0 | 0 | Against |
| Global X | 63,047 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 60,516 | 0 | 0 | Against |
| John Hancock | 0 | 50,793 | 0 | 0 | Against |
| Pacific Life | 0 | 47,089 | 0 | 0 | Against |
| JPMorgan | 0 | 46,996 | 0 | 0 | Against |
| Voya | 0 | 45,536 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 0 | 30,412 | 0 | 0 | Against |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 27,853 | 0 | 0 | 0 | For |
Showing the 25 largest of 58 asset managers. All 58 are in the interactive database (link above).
Combines 7 wordings of this item as funds reported it.
89% Majority: yes · of votes cast
Description as filed by funds: To approve amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit.
TG THERAPEUTICS INC.’s own tally for this item (“5. The vote to approve the amendment to the Company's 2022 Incentive Plan to remove the full-value awards limit”): 66,744,142 for, 8,625,685 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 89% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,622,688 | 273 | 0 | 0 | For |
| TIAA | 1,217,287 | 0 | 0 | 0 | For |
| Charles Schwab | 1,148,610 | 0 | 0 | 0 | For |
| Fidelity | 955,712 | 0 | 0 | 0 | For |
| BlackRock | 877,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 374,322 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,050 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 175,509 | 0 | 0 | 0 | For |
| First Trust | 157,249 | 0 | 0 | 0 | For |
| Goldman Sachs | 145,974 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,185 | 0 | 0 | 0 | For |
| SEI | 110,717 | 0 | 0 | 0 | For |
| ProShares | 101,760 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 72,333 | 0 | 0 | 0 | For |
| Global X | 63,047 | 0 | 0 | 0 | For |
| Guggenheim | 60,516 | 0 | 0 | 0 | For |
| John Hancock | 50,793 | 0 | 0 | 0 | For |
| Pacific Life | 47,089 | 0 | 0 | 0 | For |
| JPMorgan | 46,996 | 0 | 0 | 0 | For |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 30,412 | 0 | 0 | 0 | For |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 27,853 | 0 | 0 | 0 | For |
Fund voting reports, all 56 managers: 24,836,815 for, 22,899 against, 13,620 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Duquesne Family Office LLC | 280,000 | 0 | 0 | 0 | For |
| GRIMES & COMPANY, INC. | 6,100 | 0 | 0 | 0 | For |
| Jackson Creek Investment Advisors LLC | 2,764 | 0 | 0 | 0 | For |
| ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC | 1,000 | 0 | 0 | 0 | For |
Institutional-manager reports, all 4 managers: 289,864 for.
Combines 7 wordings of this item as funds reported it.
58% Majority: yes · of votes cast
Prior year: 37.4% for (June 14, 2023 meeting) ▲ 20.3 pts
Description as filed by funds: An advisory vote to approve the compensation of our named executive officers.
TG THERAPEUTICS INC.’s own tally for this item (“3. The advisory vote to approve the compensation of the Company's named executive officers”): 42,346,581 for, 31,019,084 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 58% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,143,664 | 3,066,304 | 0 | 0 | Mixed |
| State Street | 1,620,598 | 2,363 | 0 | 0 | For |
| TIAA | 0 | 1,217,287 | 0 | 0 | Against |
| Charles Schwab | 0 | 1,148,610 | 0 | 0 | Against |
| Fidelity | 128,804 | 826,908 | 0 | 0 | Mixed |
| BlackRock | 0 | 877,944 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 0 | 718,814 | 0 | 0 | Against |
| Equitable | 0 | 374,322 | 0 | 0 | Against |
| Lincoln Financial | 116,000 | 61,050 | 0 | 0 | Mixed |
| Direxion Shares ETF Trust | 0 | 175,509 | 0 | 0 | Against |
| First Trust | 0 | 157,249 | 0 | 0 | Against |
| Goldman Sachs | 0 | 145,974 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 127,185 | 0 | 0 | Against |
| SEI | 0 | 110,717 | 0 | 0 | Against |
| ProShares | 0 | 101,760 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 72,333 | 0 | 0 | Against |
| Global X | 0 | 63,047 | 0 | 0 | Against |
| Guggenheim | 0 | 60,516 | 0 | 0 | Against |
| John Hancock | 0 | 50,793 | 0 | 0 | Against |
| Pacific Life | 0 | 47,089 | 0 | 0 | Against |
| JPMorgan | 0 | 46,996 | 0 | 0 | Against |
| Voya | 0 | 45,536 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 0 | 30,412 | 0 | 0 | Against |
| New York Life | 0 | 28,471 | 0 | 0 | Against |
| T. Rowe Price | 0 | 27,853 | 0 | 0 | Against |
Fund voting reports, all 57 managers: 15,022,011 for, 9,849,970 against, 13,620 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| State Street | 4,030,241 | 67,165 | 0 | 0 | For |
| BlackRock | 65,922 | 3,726,811 | 0 | 0 | Against |
| Wellington | 0 | 3,119,376 | 0 | 0 | Against |
| PICTET ASSET MANAGEMENT SA | 0 | 2,994,139 | 0 | 0 | Against |
| Opaleye Management Inc. | 0 | 0 | 1,830,000 | 0 | Abstain |
| Nuveen | 0 | 1,225,330 | 0 | 0 | Against |
| Woodline Partners LP | 1,151,525 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 1,148,610 | 0 | 0 | Against |
| Vestal Point Capital, LP | 0 | 935,993 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 885,427 | 0 | 0 | Against |
| 683 Capital Management, LLC | 0 | 785,658 | 0 | 0 | Against |
| Northern Trust | 0 | 746,583 | 0 | 0 | Against |
| Hood River Capital Management LLC | 0 | 615,576 | 0 | 0 | Against |
| Point72 | 0 | 407,194 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 399,120 | 0 | 0 | Against |
| Vanguard | 395,612 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 376,682 | 0 | 0 | Against |
| Soleus Capital Management, L.P. | 360,879 | 0 | 0 | 0 | For |
| Deep Track Capital, LP | 301,832 | 0 | 0 | 0 | For |
| Duquesne Family Office LLC | 280,000 | 0 | 0 | 0 | For |
| Sofinnova Investments, Inc. | 0 | 253,478 | 0 | 0 | Against |
| Citadel | 247,989 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 243,490 | 0 | 0 | Against |
| NOMURA ASSET MANAGEMENT CO LTD | 0 | 230,893 | 0 | 0 | Against |
| Goldman Sachs | 793 | 227,394 | 0 | 0 | Against |
Institutional-manager reports, all 201 managers: 7,253,484 for, 21,016,875 against, 1,830,000 abstained, 29,688 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
99.4% Majority: yes · of votes cast
Prior year: 99.8% for (June 14, 2023 meeting) ▼ 0.4 pts
Description as filed by funds: TO RATIFY THE APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2024.
TG THERAPEUTICS INC.’s own tally for this item (“2. The ratification of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024”): 110,028,319 for, 657,578 against, per its Form 8-K filed June 17, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99.4% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 24,862,478 for, 13,620 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,209,968 | 0 | 0 | 0 | For |
| State Street | 1,622,961 | 0 | 0 | 0 | For |
| TIAA | 1,217,287 | 0 | 0 | 0 | For |
| Charles Schwab | 1,148,610 | 0 | 0 | 0 | For |
| Fidelity | 955,712 | 0 | 0 | 0 | For |
| BlackRock | 877,944 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 718,814 | 0 | 0 | 0 | For |
| Equitable | 374,322 | 0 | 0 | 0 | For |
| Lincoln Financial | 177,050 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 175,509 | 0 | 0 | 0 | For |
| First Trust | 157,249 | 0 | 0 | 0 | For |
| Goldman Sachs | 145,974 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 127,185 | 0 | 0 | 0 | For |
| SEI | 110,717 | 0 | 0 | 0 | For |
| ProShares | 101,760 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 72,333 | 0 | 0 | 0 | For |
| Global X | 63,047 | 0 | 0 | 0 | For |
| Guggenheim | 60,516 | 0 | 0 | 0 | For |
| John Hancock | 50,793 | 0 | 0 | 0 | For |
| Pacific Life | 47,089 | 0 | 0 | 0 | For |
| JPMorgan | 46,996 | 0 | 0 | 0 | For |
| Voya | 45,536 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 30,412 | 0 | 0 | 0 | For |
| New York Life | 28,471 | 0 | 0 | 0 | For |
| T. Rowe Price | 27,853 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 154,565,743 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 10.49% |
| 2 | State Street | 1.05% |
| 3 | TIAA | 0.79% |
| 4 | Charles Schwab | 0.74% |
| 5 | Fidelity | 0.62% |
| 6 | BlackRock | 0.57% |
| 7 | MUTUAL FUND SERIES TRUST | 0.47% |
| 8 | Equitable | 0.24% |
| 9 | Lincoln Financial | 0.11% |
| 10 | Direxion Shares ETF Trust | 0.11% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | State Street | 2.65% |
| 2 | BlackRock | 2.45% |
| 3 | Wellington | 2.02% |
| 4 | PICTET ASSET MANAGEMENT SA | 1.94% |
| 5 | Opaleye Management Inc. | 1.18% |
| 6 | Nuveen | 0.79% |
| 7 | Woodline Partners LP | 0.75% |
| 8 | Charles Schwab | 0.74% |
| 9 | Vestal Point Capital, LP | 0.61% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 0.57% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 21,300,425 | 13.78% | Form 13F, quarter ended March 31, 2024 |
| Vanguard Group | 15,521,299 | 10.04% | Form 13F, quarter ended March 31, 2024 |
| State Street | 7,796,579 | 5.04% | Form 13F, quarter ended March 31, 2024 |
| Millennium Management | 3,544,046 | 2.29% | Form 13F, quarter ended March 31, 2024 |
| Wellington Management | 3,153,593 | 2.04% | Form 13F, quarter ended March 31, 2024 |
| Geode Capital | 3,107,444 | 2.01% | Form 13F, quarter ended March 31, 2024 |
| Citadel Advisors | 2,448,533 | 1.58% | Form 13F, quarter ended March 31, 2024 |
| Nuveen | 1,553,490 | 1.01% | Form 13F, quarter ended March 31, 2024 |
| Goldman Sachs | 1,519,373 | 0.98% | Form 13F, quarter ended March 31, 2024 |
| Northern Trust | 1,300,388 | 0.84% | Form 13F, quarter ended March 31, 2024 |
Percentages above are of 154,565,743 shares outstanding, as reported by TG THERAPEUTICS INC. on its Form 10-Q dated March 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At TG THERAPEUTICS INC.'s shareholder meeting held June 14, 2024, in the 2023-2024 proxy season, 242 asset managers reported votes on at least one of its 10 ballot items in their SEC Form N-PX filings, covering 1,971 separate fund positions. On the most widely held item on that ballot — An advisory vote to approve the compensation of our named executive officers. — FOR was 58% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: TG THERAPEUTICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 17, 2024.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from TG THERAPEUTICS INC.’s 10-Q dated March 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
TG THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.
Proxy Votes Now, “TG THERAPEUTICS (TGTX) 2024 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/tg-therapeutics-inc/2024 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.